NCT07271628

Brief Summary

This study is a monocentric, intra-individual, controlateral design study, on the internal and posterointernal side of the forearms, to evaluate the moisturizing effect of study product AV0018B and of the persistence of this effect after repeated applications for 7 days, compared to a control area with no application of study product. The study takes place over a 8-day period and involves 2 visits :

  • Inclusion visit: Day 1 (1timepoint (Time 1) before any study product application)
  • End-of-study visit: Day 8 (2 timepoints : Time 2 : 12±2h after last application , and Time 3 : 8±4h after Time 2)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 4, 2021

Completed
24 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 28, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 28, 2021

Completed
4.1 years until next milestone

First Submitted

Initial submission to the registry

November 25, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 9, 2025

Completed
Last Updated

December 9, 2025

Status Verified

December 1, 2025

Enrollment Period

24 days

First QC Date

November 25, 2025

Last Update Submit

December 5, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cutaneous Capacitance

    Cutaneous capacitance is measured by Corneometry at posterointernal sides of forearms.

    - Visit 1 : Day 1 - Time 1 - Visit 2 : Day 8 - Time 2 (12±2hours after last application) and Time 3 (8±4hours after Time 2)

Secondary Outcomes (1)

  • Illustrative Photographs

    - Visit 1 : Day 1 - Time 1 - Visit 2 : Day 8 - Time 2 (12±2hours after last application) and Time 3 (8±4hours after Time 2)

Study Arms (2)

AV0018B application

Other: Cosmetic product AV0018B

No AV0018B application

Interventions

Cosmetic spray product AV0018B. The product is sprayed 6 times per day for 7 days. The spraying of about 3 sec is done on the inner and posterointernal side of the concerned forearm (according to randomization)

AV0018B application

Eligibility Criteria

Age20 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Subjects will be recruited from the panel of the centre (corresponding to an internal computer database whose software has been declared to the Commission Nationale Informatique et Libertés (CNIL)). If necessary, a local announcement/advertising will be done. The subjects corresponding to eligibility criteria may receive a phone call, a letter or an e-mail proposing to participate to the clinical study.

You may qualify if:

  • Females
  • Aged 20 to 55 years, inclusive
  • Phototype I to V, inclusive
  • Low hairiness and absence of prominent veins on the internal and posterointernal side of the forearms.
  • No shaving/hair removal of forearms
  • Dehydrated forearms, with HI ≤ 35 (posterointernal side of the forearms)
  • Not taking part in another clinical research study.
  • Having signed the consent form.
  • Having health insurance.

You may not qualify if:

  • Population:
  • Pregnant, breastfeeding women.
  • Subjects declaring to have hot flushes.
  • With sunburn on forearms.
  • Frequently washing their forearms for professional reasons or out of habit.
  • Subjects unable to comply with the protocol requirements.
  • Subjects deprived of freedom through a legal or administrative decision, or in care or under legal guardianship.
  • Diseases:
  • History of allergy to any of the investigational product ingredients
  • Skin lesions or skin disease on the hands, arms and forearms.
  • Type 1 diabetes.
  • Unresolved viral hepatitis.
  • Chronic cardiovascular, endocrine, rheumatological and urogenital system and non-stabilized neuropsychiatric disorders (treatment started less than 2 months ago).
  • Acute pathology (infectious, inflammatory).
  • Dermatological condition or skin lesion on the top of the cheekbone liable to interfere with the samplings according to the investigator's opinion.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Skin Research Center

Toulouse, France, 31300, France

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2025

First Posted

December 9, 2025

Study Start

October 4, 2021

Primary Completion

October 28, 2021

Study Completion

October 28, 2021

Last Updated

December 9, 2025

Record last verified: 2025-12

Locations